HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Description of a novel TUBA1A mutation in Arg-390 associated with asymmetrical polymicrogyria and mid-hindbrain dysgenesis.

Abstract
Mutations of TUBA1A gene were first identified as causing a distinctive neuroradiologic phenotype characterized by cortical abnormalities ranging from classical lissencephaly to perisylvian pachygyria with dysgenetic corpus callosum, brainstem and cerebellum. We describe the clinical and neuroradiological features of a 3 years old girl carrying a novel missense TUBA1A mutation associated with asymmetrical polymicrogyria and provide structural data about the mutation. Our case confirm that the spectrum of tubulin-related cortical phenotypes is wide and that the screening of these genes should be implemented in patients with mid-hindbrain dysgenesis, partial of complete corpus callosum agenesis and varying degrees of cortical abnormalities.
AuthorsGinevra Zanni, Giovanna S Colafati, Sabina Barresi, Francesco Randisi, Lorenzo Figà Talamanca, Elisabetta Genovese, Emanuele Bellacchio, Andrea Bartuli, Bruno Bernardi, Enrico Bertini
JournalEuropean journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society (Eur J Paediatr Neurol) Vol. 17 Issue 4 Pg. 361-5 (Jul 2013) ISSN: 1532-2130 [Electronic] England
PMID23317684 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • TUBA1A protein, human
  • Tubulin
Topics
  • Animals
  • Child, Preschool
  • Computational Biology
  • DNA Mutational Analysis
  • Female
  • Humans
  • Lissencephaly (complications, genetics)
  • Magnetic Resonance Imaging
  • Malformations of Cortical Development (complications, genetics)
  • Models, Molecular
  • Mutation (genetics)
  • Tubulin (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: